The VertiGO! Trial protocol: A prospective, single-center, patient-blinded study to evaluate efficacy and safety of prolonged daily stimulation with a multichannel vestibulocochlear implant prototype in bilateral vestibulopathy patients

Vermorken, Bernd L. and Volpe, Benjamin and van Boxel, Stan C. J. and Stultiens, Joost J. A. and van Hoof, Marc and Marcellis, Rik and Loos, Elke and van Soest, Alexander and McCrum, Chris and Meijer, Kenneth and Guinand, Nils and Pérez Fornos, Angélica and van Rompaey, Vincent and Devocht, Elke and van de Berg, Raymond and Melo, Renato S. (2024) The VertiGO! Trial protocol: A prospective, single-center, patient-blinded study to evaluate efficacy and safety of prolonged daily stimulation with a multichannel vestibulocochlear implant prototype in bilateral vestibulopathy patients. PLOS ONE, 19 (3). e0301032. ISSN 1932-6203

[thumbnail of journal.pone.0301032.pdf] Text
journal.pone.0301032.pdf

Download (1MB)

Abstract

Background
A combined vestibular (VI) and cochlear implant (CI) device, also known as the vestibulocochlear implant (VCI), was previously developed to restore both vestibular and auditory function. A new refined prototype is currently being investigated. This prototype allows for concurrent multichannel vestibular and cochlear stimulation. Although recent studies showed that VCI stimulation enables compensatory eye, body and neck movements, the constraints in these acute study designs prevent them from creating more general statements over time. Moreover, the clinical relevance of potential VI and CI interactions is not yet studied. The VertiGO! Trial aims to investigate the safety and efficacy of prolonged daily motion modulated stimulation with a multichannel VCI prototype.

Methods
A single-center clinical trial will be carried out to evaluate prolonged VCI stimulation, assess general safety and explore interactions between the CI and VI. A single-blind randomized controlled crossover design will be implemented to evaluate the efficacy of three types of stimulation. Furthermore, this study will provide a proof-of-concept for a VI rehabilitation program. A total of minimum eight, with a maximum of 13, participants suffering from bilateral vestibulopathy and severe sensorineural hearing loss in the ear to implant will be included and followed over a five-year period. Efficacy will be evaluated by collecting functional (i.e. image stabilization) and more fundamental (i.e. vestibulo-ocular reflexes, self-motion perception) outcomes. Hearing performance with a VCI and patient-reported outcomes will be included as well.

Discussion
The proposed schedule of fitting, stimulation and outcome testing allows for a comprehensive evaluation of the feasibility and long-term safety of a multichannel VCI prototype. This design will give insights into vestibular and hearing performance during VCI stimulation. Results will also provide insights into the expected daily benefit of prolonged VCI stimulation, paving the way for cost-effectiveness analyses and a more comprehensive clinical implementation of vestibulocochlear stimulation in the future.

Item Type: Article
Subjects: EP Archives > Biological Science
Depositing User: Managing Editor
Date Deposited: 05 Apr 2024 10:41
Last Modified: 05 Apr 2024 10:41
URI: http://research.send4journal.com/id/eprint/3836

Actions (login required)

View Item
View Item